Player FM 앱으로 오프라인으로 전환하세요!
Imran House and Junyun Lai Discuss CRISPR Screening in Immuno-Oncology
Manage episode 398454707 series 2430750
Imran House, Ph.D. and Junyun Lai Ph.D. are Senior Scientists at the biotech start-up, oNKo-Innate in Melbourne, Australia that focuses on developing immuno-oncology therapies. In this episode, they discussed what they do at oNKo-innate, their career transitions from leaving academics to entering the biotech industry, and how CRISPR is impacting cancer-immunotherapy development. They also discussed overcoming common obstacles faced when developing cytokine therapies and future outlooks on clinical trials using these kinds of therapies.
Reach out and connect with both Imran and Junyun on social media platforms:
Imran House, Ph.D.
X: @ImranHouse
Junyun Lai, Ph.D.
X: @JunyunLai
44 에피소드
Manage episode 398454707 series 2430750
Imran House, Ph.D. and Junyun Lai Ph.D. are Senior Scientists at the biotech start-up, oNKo-Innate in Melbourne, Australia that focuses on developing immuno-oncology therapies. In this episode, they discussed what they do at oNKo-innate, their career transitions from leaving academics to entering the biotech industry, and how CRISPR is impacting cancer-immunotherapy development. They also discussed overcoming common obstacles faced when developing cytokine therapies and future outlooks on clinical trials using these kinds of therapies.
Reach out and connect with both Imran and Junyun on social media platforms:
Imran House, Ph.D.
X: @ImranHouse
Junyun Lai, Ph.D.
X: @JunyunLai
44 에피소드
모든 에피소드
×플레이어 FM에 오신것을 환영합니다!
플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.